In this article, we take a look at five biotech companies developing potentially transformative medicines to treat cystic ...

In a small Phase IIa trial, Insilico’s generative AI-designed idiopathic pulmonary fibrosis drug improved lung function and ...

People with cystic fibrosis (CF) have higher chloride levels ... with abnormal screening results or for individuals showing symptoms of CF. In babies and children, chronic coughing, frequent ...

In people with cystic fibrosis (CF), bone turnover is imbalanced ... Imbalanced bone turnover may not cause immediately noticeable symptoms in people with CF, especially in the early years.

Cirrhosis, hepatitis infection and other causes can trigger liver fibrosis—a potentially lethal stiffening of tissue that, ...

Researchers explore the mechanisms, therapeutic potential, and clinical applications of curcumin in preventing and treating ...

Identifying the underlying causes of prolonged lung inflammation associated with radiographic abnormalities could be key understanding long COVID and other lung conditions, researchers say.

Novo Nordisk's semaglutide trial showed 62.9% of patients experienced resolution of symptoms with no worsening of scarring. "Novo Nordisk's Weight-Loss Drug Helps Improve Symptoms of Liver Disease, ...

According to Headline results from part 1 of the phase 3 ESSENCE trial, Semaglutide 2.4 mg may significantly improve liver ...

Novo Nordisk today announced the headline results from part 1 of the ongoing ESSENCE trial, a pivotal phase 3, 240-week, ...

The EVOLVED trial found that early aortic valve intervention in patients with asymptomatic severe aortic stenosis (AS) and ...

Met primary objective demonstrating nintedanib DPI was safe and well toleratedParticipants did not experience adverse events typically reported ...